Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.2.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.2.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.23.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.23.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.23.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.316EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.316EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.316ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.316ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.316EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.316EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.316ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.316ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.436EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.436EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.436ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.436ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.436EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.436EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.436ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.436ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.558EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.558EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.558ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.558ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.558EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.558EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.558ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.558ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.518EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.216EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.216EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.216ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used